ALS  ONLINE  GENETICS  DATABASE
You are here ==> Skip Navigation LinksHome --> Gene Overview
We use session cookies to determine the frequency of unique visits to the ALSoD website. Session cookies do not collect information from the user's computer and are used to maintain a session identification between server and client. They do not personally identify the user. If you continue, we'll assume that you are happy to receive all cookies on the ALSoD website.

Submit gene, mutation and patient data now

Log In
 
 
Forgot password?

 If you wish to contribute data you must REGISTER

ALSoD is a joint project of World Federation of Neurology and European Network to Cure ALS
European ALS ConsortiumWorld Federation of Neurology

ALSoD is funded by
ALS AssociationALS Society of CanadaMND AssociationMND Association IcelandGlaxoSmithKlineIngenuity SystemsALS Therapy Alliance
Since 03/01/09
Viewed  737611  times,
Visited by
43248
Unique Users
You are accessing from
  Unknown
Last Update
23th May 2013 


GENE OVERVIEW OF KEY PUBLISHED STUDIES FOR ALS


GeneSMN2
Other namesSMNC; BCD541; MGC5208; C-BCD541; FLJ76644; MGC20996
Gene namesurvival of motor neuron 2, centromeric
Gene inheritance categorySALS genes
CategoryALTERED DNA/RNA PROCESSING
Chromosome5q13.2
BackgroundComponent of an import snRNP complex, interact with with several spliceosomal snRNP core Sm proteins. SMN protects cells against mutant SOD1 toxicity by increasing chaperone activity.
ResultSMN genotypes which reduce SMN protein levels associated with SALS
Total Mutations0
Total Affected0

BIOINFORMATICS

Entrez Gene   UCSC Browser   Protein Structure   OMIM   Genecards   Full Literature   ProtScale  Sequence    Uniprot
iHop   Pathway   GeneTest   ALS review                       
GeneMANIA   AmiGO   Gene Wiki   Wolfram Alpha   Ensembl   NCBI   WikiGenes   Life Science DB(Japan)   ALSGene      GeneNetwork

KEY PUBLICATIONS (6)

First_AuthorYearTitlePaper
Corcia2002Abnormal SMN1 gene copy number is a susceptibility factor for amyotrophic lateral sclerosisFull_Paper
Corcia2002SMN1 gene study in three families in which ALS and spinal muscular atrophy co-existFull_Paper
Gamez2002Survival and respiratory decline are not related to homozygous SMN2 deletions in ALS patientsFull_Paper
Veldink2001Homozygous deletion of the survival motor neuron 2 gene is a prognostic factor in sporadic ALSFull_Paper
Veldink2005SMN genotypes producing less SMN protein increase susceptibility to and severity of sporadic ALSFull_Paper
Zou2007SMN protects cells against mutant SOD1 toxicity by increasing chaperone activityFull_Paper

GENETIC VARIATIONS

SNP (rs)BasepairpvalueAuthorYearTermPaper
 113002025655700.2Gamez2002GRCh37Survival and respiratory decline are not related to homozygous SMN2 deletions in ALS patients
 22766152025981130.69Gamez2002GRCh37Survival and respiratory decline are not related to homozygous SMN2 deletions in ALS patients
 23026252026225080.09Gamez2002GRCh37Survival and respiratory decline are not related to homozygous SMN2 deletions in ALS patients
 32191522026456330.32Gamez2002GRCh37Survival and respiratory decline are not related to homozygous SMN2 deletions in ALS patients
 32191532026335820.65Gamez2002GRCh37Survival and respiratory decline are not related to homozygous SMN2 deletions in ALS patients
 32191542026264370.99Gamez2002GRCh37Survival and respiratory decline are not related to homozygous SMN2 deletions in ALS patients
 32191552026262420.99Gamez2002GRCh37Survival and respiratory decline are not related to homozygous SMN2 deletions in ALS patients
 32191562026256150.34Gamez2002GRCh37Survival and respiratory decline are not related to homozygous SMN2 deletions in ALS patients
 32191572026193330.99Gamez2002GRCh37Survival and respiratory decline are not related to homozygous SMN2 deletions in ALS patients
 32191582026178660.99Gamez2002GRCh37Survival and respiratory decline are not related to homozygous SMN2 deletions in ALS patients
 32191592026111380.4Gamez2002GRCh37Survival and respiratory decline are not related to homozygous SMN2 deletions in ALS patients
 32191602026065070.99Gamez2002GRCh37Survival and respiratory decline are not related to homozygous SMN2 deletions in ALS patients
 32191612025932800.67Gamez2002GRCh37Survival and respiratory decline are not related to homozygous SMN2 deletions in ALS patients
 32191622025916070.99Gamez2002GRCh37Survival and respiratory decline are not related to homozygous SMN2 deletions in ALS patients
 32191632025892570.14Gamez2002GRCh37Survival and respiratory decline are not related to homozygous SMN2 deletions in ALS patients
 32191642025881880.99Gamez2002GRCh37Survival and respiratory decline are not related to homozygous SMN2 deletions in ALS patients
 32191652025877150.2Gamez2002GRCh37Survival and respiratory decline are not related to homozygous SMN2 deletions in ALS patients
 32191662025828950.55Gamez2002GRCh37Survival and respiratory decline are not related to homozygous SMN2 deletions in ALS patients
 32191672025803700.72Gamez2002GRCh37Survival and respiratory decline are not related to homozygous SMN2 deletions in ALS patients
 32191682025758210.74Gamez2002GRCh37Survival and respiratory decline are not related to homozygous SMN2 deletions in ALS patients
 32191692025715620.22Gamez2002GRCh37Survival and respiratory decline are not related to homozygous SMN2 deletions in ALS patients
 32191702025702320.76Gamez2002GRCh37Survival and respiratory decline are not related to homozygous SMN2 deletions in ALS patients
 32191712025699920.002Gamez2002GRCh37Survival and respiratory decline are not related to homozygous SMN2 deletions in ALS patients
 32191722025664110.99Gamez2002GRCh37Survival and respiratory decline are not related to homozygous SMN2 deletions in ALS patients
 32191732025661270.1Gamez2002GRCh37Survival and respiratory decline are not related to homozygous SMN2 deletions in ALS patients
 32191742025656810.54Gamez2002GRCh37Survival and respiratory decline are not related to homozygous SMN2 deletions in ALS patients
 69366468 Gamez2002GRCh37Survival and respiratory decline are not related to homozygous SMN2 deletions in ALS patients
        
 
© Copyright 1999-2013 King's College London, The Institute of Psychiatry | Rewritten + Version 3.0 by Olubunmi Abel | Project coordinated by Prof Ammar Al-Chalabi